Neuronal activity regulated pentraxin (narp) and GluA4 subunit of AMPA receptor may be targets for fluoxetine modulation
Authors:
- 2 February 2021
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 36 (4) , 711-722
Abstract
Fluoxetine is the foremost prescribed antidepressant. Drugs acting on monoaminergic system may also regulate glutamatergic system. Indeed, the investigation of proteins associated with this system, such as Narp (neuronal activity-dependent pentraxin) and GluA4 subunit of AMPA receptor may reveal poorly explored modulations triggered by conventional antidepressants. This study aimed to uncover neurochemical mechanisms underlying the chronic fluoxetine treatment, mainly by evaluating these protein targets in the prefrontal cortex and in the hippocampus. Mice received a daily administration of fluoxetine (0.1, 1 or 10 mg/kg, p.o.) or potable water (vehicle group) for 21 days. These animals were submitted to the forced swim test (FST) to verify antidepressant-like responses and the open-field test (OFT) to assess locomotor activity. Modulation of signaling proteins was analyzed by western blot. Chronic treatment with fluoxetine (1 and 10 mg/kg) was effective, since it reduced the immobility time in the FST, without altering locomotor activity. Fluoxetine 10 mg/kg increased CREB phosphorylation and BDNF expression in the prefrontal cortex and hippocampus. Noteworthy, in the hippocampus fluoxetine also promoted Akt activation and augmented Narp expression. In the prefrontal cortex, a significant decrease in the expression of the GluA4 subunit and Narp were observed following fluoxetine administration (10 mg/kg). The results provide evidence of novel molecular targets potentially involved in the antidepressant effects of fluoxetine, since in mature rodents Narp and GluA4 are mainly expressed in the GABAergic parvalbumin-positive (PV+) interneurons. This may bring new insights into the molecular elements involved in the mechanisms underlying the antidepressant effects of fluoxetine.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (#439601/2018-5; #309048/2019-2)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES/MINCyT Project #249/14)
- Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (NENASC-PRONEX Projectc#1262/2012-9))
This publication has 107 references indexed in Scilit:
- Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjectsInternational Journal of Neuropsychopharmacology, 2013
- Paradoxical proepileptic response to NMDA receptor blockade linked to cortical interneuron defect in stargazer miceFrontiers in Cellular Neuroscience, 2013
- A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental healthJournal of Psychiatry and Neuroscience, 2012
- Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agentsTrends in Neurosciences, 2012
- How Inhibition Shapes Cortical ActivityNeuron, 2011
- Three groups of interneurons account for nearly 100% of neocortical GABAergic neuronsDevelopmental Neurobiology, 2010
- Categorical speech representation in human superior temporal gyrusNature Neuroscience, 2010
- Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneuronsNature Neuroscience, 2010
- Signaling Mechanisms Linking Neuronal Activity to Gene Expression and Plasticity of the Nervous SystemAnnual Review of Neuroscience, 2008
- Chronic Fluoxetine Treatment Induces Brain Region-Specific Upregulation of Genes Associated with BDNF-Induced Long-Term PotentiationNeural Plasticity, 2007